Catalyst Clinical Research Announces Acquisition of Genpro Research
Catalyst Clinical Research announced it has acquired Genpro Research, a Massachusetts-based global clinical research organization with staff in the US, India, and Ireland.
Genpro is a services and technology partner for the pharmaceutical, biotechnology, and medical devices industry with expertise in biometrics, medical writing, RWE, and AI-enabled automation product development. Genpro will continue to be led by Sachin Marulkar, MD, MPH, MBA and the existing management team.
This acquisition adds more than 120 team members in India with expertise in biometrics and medical writing. This further enables biopharma, MedTech and CRO clients (current and future) to access Catalyst's clinical research services, along with broader expertise in global time zones, new solutions, and early access to innovative automation platforms.
Reference
Catalyst Clinical Research Announces the Acquisition of Genpro Research. (2023, July 21). Cision PR Newswire.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
